IAG’s team experience with using DXA and X-ray in clinical trials spans over 40 years, with the company supporting large registrational studies and research PoC projects, since 2016. We understand the value of time and transparency in clinical development, and power our trials with DYNAMIKA platform. It is designed to efficiently process imaging data, support all trial stakeholders, deliver results via reports or dashboards. Thus, helping our partners, readers and sponsors to fast decisions.

Read our case studies: from saving significant budgets: ‘35% Trial Budget Reduction’ to ‘Reducing Length & Cost of Trials through Patient Stratification‘.

Case Study: One specific study, involving DXA analysis makes a vivid example. In 2021, IAG was contacted by a large European biotech company to support their Phase III trial. The objective was to utilize X-ray and DXA scans for combined eligibility as one of the criteria for the inclusion / exclusion of patients in their protocol. The Sponsor was looking for experts in the field, who can bring global network of sites, and execute screening with speed. IAG’s team partnered with the CRO and together we embarked on accelerating recruitment. The Study recruited faster than exepcted, saving Sponsor significant time and money. The data is currently being finalized to be submitted for regulatory review.

Image Analysis Group is a unique partner to life sciences companies. Our goal is to accelerate novel drug developments, by using the right analytical tools and a modern trial infrastructure. At IAG, we are committed to helping our biotech and pharma partners to efficiently develop novel life-changing medicines, accelerating their R&D pipelines through advanced analytics, IAG’s technology solutions and imaging contract research services. We see each project as an oportunity to build a long lasting partnership and to become an extension of your team.